fluorexon has been researched along with Carcinoma, Small Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broxterman, HJ; Dingemans, AM; Flens, MJ; Gazdar, AF; Giaccone, G; Pinedo, HM; Rubio, GJ; Scheper, RJ; van Ark-Otte, J | 1 |
1 other study(ies) available for fluorexon and Carcinoma, Small Cell
Article | Year |
---|---|
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Biological Transport; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; DNA, Complementary; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluoresceins; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Tumor Cells, Cultured | 1996 |